◆ 会议时间：2025年3月5-8日
◆ 会议地点：意大利 佛罗伦萨

◆ 会议简介：

2025年第23届欧洲内科医学大会(ECIM 2025)将于2025年3月5-8日在意大利佛罗伦萨举行，会议由欧洲内科医学联合会(EFIM)主办。欧洲内科医学大会(ECIM)是欧洲内科医学联合会（EFIM）的官方会议，ECIM是医生、科学家和其他内科领域的专家交流有关科学和临床实践进展最新信息的重要活动。ECIM将关注创新发展，并全面概述内科医学中常见病的最新治疗方法。

欧洲内科医学联合会（EFIM）源于1969年成立于欧洲内科医学协会（AEMI），1996年改为现名。EFIM是由来自欧盟各国、欧盟内外的国家内科学会组成，现包括35个会员学会，代表着欧洲4万多名内科医生，是欧洲最大的内科专业协会。EFIM的宗旨是重新强调在日益专业化的世界中内科医学的重要性。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）。

23rd European Congress of Internal Medicine (ECIM 2025) 

Date:
5-8 March 2025

Venue:
Firenze Fiera S.p.A. Congress & Exhibition Center
Florence, Italy

摘要征文投稿：

Abstract Submission 3 June – 31 October 2024

Late Breaking Submission 4 – 22 November 2024

Abstract Notification Friday, 5 January 2025

Abstract Notification (Late Breaking) Friday, 26 January 2025

点此提交摘要>>>Submit Abstract>>>

RULES FOR SUBMISSION

Please read the submission rules before submitting an abstract.

RULES FOR SUBMISSION

Please read the submission rules before submitting an abstract.

• Abstracts will be collected by online abstract system .
• ABSTRACTS SUBMITTED BY EMAIL WILL NOT BE ACCEPTED.
• Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.
• Abstracts may be submitted for oral presentation or poster presentation.
• Presenting authors must be registered participants. Only abstracts of authors who have paid their registration fees will be scheduled for presentation and included for publication.
• A single attendee can act as the presenting author for a maximum of 5 abstracts. 
• By submitting an abstract, you acknowledge your consent for it to be published in the official meeting publication. 
• All abstracts should be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university specific publications office (or other similar facility) or by a copy editor, prior to submission.
• The submitter should have ensure that the patient consent is obtained before submitting the abstract.
• Only abstracts with results will be accepted for review. Abstracts stating “data will be discussed in the presentation” will NOT be accepted.
• Not: Abstracts that have been previously submitted to a national congress may also be submitted to ECIM 2024. However, those that have been submitted to an international congress may not be submitted again.
• The Scientific Committee will make the final decision as to whether the abstract will be accepted for presentation, with consideration given to the author’s preference.
• Academic titles should not be used in author names.
• Abstract structure – abstracts should clearly state:

• Research/Medical Abstracts should follow this structure:
  • Background/Aims
  • Materials and Methods
  • Results
  • Discussion and conclusion

• Case Reports/Clinical Cases should follow this structure:
  • Background
  • Case description
  • Clinical hypothesis
  • Diagnostic pathway
  • Discussion and learning points 

• The abstract must not exceed 250 words including references. Title, authors’ names, affiliations and tables and figures are not included in the word count. 
• Tables and Figures must be referenced in the text and numbered in the order they appear. All tables and figure must be accompanied by a caption and list of abbreviations whenever appropriate (e.g., Figure 1: description /Table 1: description). 

• The authors’ affiliation should be clearly indicated as follows: Department, Institution, City, Country (e.g., Department of XXXXX, University of XXXX, Istanbul, Turkey). Please note that the country names should be spelled in English.

• Abstract title – must be in UPPER CASE and limited to 25 words. Please submit symbols as words. e.g. Beta, alpha, etc. 

• You may enter up to 3 keywords, separated by commas (e.g., word 1, word 2, word 3)

• Abbreviations and acronyms should be spelled in full and followed by the abbreviation/acronym in a parenthesis the first time they are mentioned in the abstract. E.g. Systemic lupus erythematosus (SLE) is a rare disease. SLE was diagnosed in 5 out of 10 patients… 

• Use generic names of drugs in small letters and not trade names. Abstract content must be scientifically valid, objective and balanced and contain no commercial promotional content.

• Do not include patient names within the text or figures, as well as any hospital patient ID codes or other details that could potentially reveal patient identities. Figures showing patients faces should be modified and at least eyes should be covered or blurred. 

Abstract Categories

1. Research/Medical Abstracts
2. Case Reports/Clinical Cases

Submission Process

• Register to the system using the “New User” link and create a new account.
• After signing up, follow the instructions provided on the page. Please read these messages and instructions carefully.
• A confirmation message will be sent to the corresponding author’s e-mail address after the abstract submission is completed. Please keep this confirmation email. If this email doesn’t appear, check your spam folder.
• The entire evaluation process can be tracked through the corresponding author’s account and e-mail.
• If you have not received confirmation that your abstract has been submitted, please contact us. Do not submit multiple copies of the same abstract.
• For technical support or questions during submission, contact LookUs Information Services Ltd at Tel: +90 (216) 372 66 44 from 08:00 to 17:00 on weekdays (Istanbul time), or email ecim2025@brosgroup.net.

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。